MyMD Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MyMD Pharmaceuticals generated cash of -$12,980,625, which is less than the previous year. Cash used in financing activities reached the amount of $13,066,819 last year. Net change in cash is therefore $1,931,920.
Cash Flow
| 2014 | -3.88M | -9.28M | 13.52M |
|---|---|---|---|
| 2015 | -5.13M | 5.07M | 0 |
| 2016 | -4.17M | 3.84M | 0 |
| 2017 | -5.08M | -5.01M | 10.46M |
| 2018 | -8.51M | -344.50K | 9.10M |
| 2019 | -3.07M | -3.94M | 6.96M |
| 2020 | -4.66M | -8.75M | 4.67M |
| 2021 | -19.51M | 19.85M | 73.53K |
| 2022 | -12.27M | 6.91M | 5.55M |
| 2023 | -12.98M | 1.84M | 13.06M |
MYMD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 749.09K | 555.96K | 148.28K | 134.49K | 181.75K | 438.43K | 72.7K | 402.05K | 455.84K | 103.63K |
Operating activities | ||||||||||
Net income | -3.99M | -15.19M | -29.88M | -9.48M | -3.38M | -10.84M | -7.36M | -3.30M | -9.31M | -3.12M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 18.33K | 74.06K | 234.48K | 249.89K | 286.16K | 299.99K | 349.39K |
Stock-based compensation expense | 3.04M | 695.19K | 15.03M | 2.86M | 3.57M | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 3.04M | 695.19K | 15.03M | 2.86M | 3.57M | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 42.88K | 128.12K | 631.51K | -781.50K | -138.65K | 635.59K | -1.89M |
Inventories | 0 | 0 | 0 | 197.72K | 14.28K | 83.31K | -119.61K | -187.2K | -226.53K | 123.04K |
Accounts payable | 1.04M | 1.68M | -4.26M | -240.60K | -443.73K | 188.46K | 87.60K | 234.06K | 827.60K | 538.01K |
Cash generated by operating activities | -12.98M | -12.27M | -19.51M | -4.66M | -3.07M | -8.51M | -5.08M | -4.17M | -5.13M | -3.88M |
Investing activities | ||||||||||
Purchases Of Investments | -13.45M | -4.83M | -13.40K | -9.87M | -6.70M | -6.58M | -7.70M | -35.94K | -125.03K | -12.55M |
Investments In Property Plant And Equipment | 0 | 0 | -1.38M | 0 | 0 | -68.21K | -54.50K | -123.30K | -112.95K | -24.98K |
Acquisitions Net | 0 | 0 | 1.38M | 0 | 6.25K | 0 | 7.76M | 0 | 0 | 0 |
Cash generated by investing activities | 1.84M | 6.91M | 19.85M | -8.75M | -3.94M | -344.50K | -5.01M | 3.84M | 5.07M | -9.28M |
Financing activities | ||||||||||
Common Stock Issued | 14.68M | 5.55M | 0 | 1.98M | 6.96M | 9.10M | 10.46M | 0 | 0 | 13.10M |
Payments for dividends | -1.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -89.63K | 0 | 0 | 1.74M | 4.81M | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -3.06M | -1.42K | 0 | 0 | 0 | 0 | 0 | -307.5K |
Cash used in financing activities | 13.06M | 5.55M | 73.53K | 4.67M | 6.96M | 9.10M | 10.46M | 0 | 0 | 13.52M |
Net Change In Cash | 1.93M | 193.12K | 407.68K | 13.78K | 335.68K | -256.67K | 365.73K | -329.35K | -53.78K | 352.20K |
Cash at end of period | 2.68M | 749.09K | 555.96K | 148.28K | 517.44K | 181.75K | 438.43K | 72.7K | 402.05K | 455.84K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |